Financial Calendar

14 Feb, 2019

Year-end report

January to December 2018

3 May, 2019

Interim report, quarter 1

January to March 2019

22 May, 2019

Annual General Meeting

18 Jul, 2019

Interim report, quarter 2

January to June 2019

7 Nov, 2019

Interim report, quarter 3

January to September 2019

13 Feb, 2020

Year-end report

January to December 2019

13 Apr, 2020

Annual Report 2019

January to December 2019

7 May, 2020

Interim report, quarter 1

January to March 2020

26 May, 2020

Annual General Meeting

16 Jul, 2020

Interim report, Q2

January to June 2020

2 Sep, 2020

Pareto Securities’ 11th Annual Healthcare Conference

Q-linea CEO, Jonas Jarvius will hold a presentation on September 2, 09.00 - 09.30 Learn more

21 Oct, 2020

Redeye Diagnostics 2020

Q-linea CEO Jonas Jarvius, presents at Redeye Diagnostics 2020 View the entire presentation here : Watch now Documents: Presentation.pdf

5 Nov, 2020

Interim report, Q3

January to September 2020

26 Nov, 2020

Redeye Life Science Day

We are participating in Redeye Life Science Day, November 26. Q-linea CEO, Jonas Jarvius holds a presentation between 09.30 - 09.50. The presentation will be streamed live here: To...

18 Feb, 2021

Year-end report

Year-end report 2020, January to December 2020

12 Apr - 16 Apr, 2021

Annual report 2020

Annual report 2020

6 May, 2021

Interim report, Q1

Interim report, Q1, January to March 2021

25 May, 2021

Annual General Meeting

Annual General Meeting 2021

15 Jul - 15 Jul, 2021

Interim report Q2

Interim report Q2, January to June 2021

4 Nov - 4 Nov, 2021

Interim report Q3

Interim report Q3, January - September 2021

17 Feb - 17 Feb, 2022

Year End Report

January – December 2021

11 Apr - 17 Apr, 2022

Annual Report 2021

Q-lineas' annual report for the fiscal year 2021 will be published during the week beginning with 11 April, 2022

5 May - 5 May, 2022

Interim report, Q1

January – March 2022

24 May - 24 May, 2022

Annual General Meeting

14 Jul - 14 Jul, 2022

Interim report, Q2

January – June 2022

3 Nov - 3 Nov, 2022

Interim report, Q3

January – September 2022